Such findings provide novel mechanistic insight into the pathogenesis of HAND and highlight TLR7 as a potential therapeutic target for HAND (Dominguez‐Villar et al. 2015; Lederman 2015). This evidence concerns the gene TLR7 and HIV-associated neurocognitive disorder.